Renal Cell Carcinoma – How Can We Predict its Outcomes in Clinical Practice?

1. Bedke J, Buse S, Pritsch M, et al. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences // BJU International, 2009; 103(10):1349-1354Search in Google Scholar

2. Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma // Am J Surg Pathol, 2003; 27:612-624Search in Google Scholar

3. Choueiri TK, Garcia JA, Elson P, et al. Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy // Cancer, 2007; 110:543-550Search in Google Scholar

4. Culp SH, Tannir NM, Abel EJ, et al. Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? // Cancer, 2010; 116:3378-3388Search in Google Scholar

5. de Reijke TM, Bellmunt J, van Poppel H, et al. EORTC-GU group expert opinion on metastatic renal cell cancer // Eur J Cancer, 2009; 45:765-773Search in Google Scholar

6. Eggener SE, Yossepowitch O, Pettus JA, et al. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence // J Clin Oncol, 2006; 24(19):3101-3106Search in Google Scholar

7. Elson PJ, Witte RS, Trump DL. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma // Cancer Res, 1988; 48:7310-7313Search in Google Scholar

8. Escudier B, Choueiri TK, Oudard S, et al. Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941 // J Urol, 2007; 178:1901-1905Search in Google Scholar

9. Escudier B, Kataja V; ESMO Guidelines Working Group. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up // Ann Oncol, 2010; 21(5):137-139Search in Google Scholar

10. European Cancer Observatory (ECO) // eco.iarc.frSearch in Google Scholar

11. Finley DS, Pantuck AJ, Belldegrun AS. Tumor biology and prognostic factors in renal cell carcinoma // Oncologist, 2011; 16(2):4-13Search in Google Scholar

12. Flanigan RC, Salmon SE, Blumenstain BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer // N Engl J Med, 2001; 345:1655Search in Google Scholar

13. Frank I, Blute ML, Cheville JC, et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score // J Urol, 2002; 168:2395-2400Search in Google Scholar

14. Heng DY, Xie W, Regan MM, et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study // J Clin Oncol, 2009; 27:5794Search in Google Scholar

15. Hudes G, Carducci M, Tomczk P, et al. Temsirolimus, interferon alfa, or both for advanced renal‐cell carcinoma // N Engl J Med, 2007; 356, 2271-228110.1056/NEJMoa06683817538086Search in Google Scholar

16. Ii mura Y, Saito K, Fujii Y, et al. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score // J Urol, 2009; 181(3):1004-1012Search in Google Scholar

17. Is barn H, Karakiewicz PI. Predicting cancer-control outcomes in patients with renal cell carcinoma // Curr Opin Urol, 2009; 19(3):247-257Search in Google Scholar

18. Je ldres C, Karakiewicz PI, Suardi N, et al. Conditional survival predictions after nephrectomy for renal cell carcinoma // J Urol, 2009; 182(6):2607-2612Search in Google Scholar

19. Je ppesen AN, Jensen HK, Donskov F, et al. Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma // Br J Cancer, 2010; 102:867Search in Google Scholar

20. Ka volius JP, Mastorakos DP, Pavlovich C, et al. Resection of metastatic renal cell carcinoma // J Clin Oncol, 1998; 16:2261-2266Search in Google Scholar

21. Ki m HL, Belldegrun AS, Freitas DG, et al. A Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis // J Urol, 2003; 170:1742-1746Search in Google Scholar

22. Kim HL, Seligson D, Liu X, et al. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma // J Urol, 2005; 173(5):1496-1501Search in Google Scholar

23. Kuti kov A, Egleston BL, et al. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram // J Clin Oncol, 2010; 28(2):311-317Search in Google Scholar

24. Kuti kov A, Smaldone MC, Egleston, et al. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score // Eur Urol, 2011; 60(2):241-248Search in Google Scholar

25. Lee CT, Katz J, Fearn PA, et al. Mode of presentation of renal cell carcinoma provides prognostic information // Urol Oncol, 2002; 7:135-140Search in Google Scholar

26. Lee LS, Tan MH. Predictive models for the practical management of renal cell carcinoma// Nat Rev Urol, 2012; 9(2):73-84Search in Google Scholar

27. Leib ovich BC, Cheville JC, Lohse CM, et al. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials // J Urol, 2005; 174:1759-176328. Ljun gberg B, Cowan NC B, Cowan NC, et al. EAU guidelines on renal cell carcinoma: the 2010 update // Eur Urol, 2010; 58:398-406Search in Google Scholar

29. Mano la J, Royston P, Elson P, et al. Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group // Clin Cancer Res, 2011; 17(16):5443-5450Search in Google Scholar

30. Moch H, Gasser T, Amin MB, et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors // Cancer, 2000; 89:604-614Search in Google Scholar

31. Motz er RJ, Agarwal N, Beard C, et al. NCCN clinical practice guidelines in oncology: kidney cancer. Version 2.2012 // J Natl Compr Canc Netw, 2009; 7:618-30Search in Google Scholar

32. Motz er RJ, Bacik J, Mazumdar M. Prognostic factors for survival of patients with stage IV renal cell carcinoma: Memorial Sloan - Kettering Cancer Center experience // Clin Cancer Res, 2004; 10:6302-6303Search in Google Scholar

33. Motz er RJ, Bacik J, Murphy BA, et al. Interferon- alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma // J Clin Oncol, 2002; 20:289-296Search in Google Scholar

34. Motz er RJ, Bukowski RM, Figlin, et al. Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma // Cancer, 2008; 113:1552-1558Search in Google Scholar

35. Negr ier S, Gomez F, Douillard JY, et al. Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d’Immunotherapie // World J Urol, 2005; 23:161-165Search in Google Scholar

36. Park er AS, Leibovich BC, Lohse CM, et al. Development and evaluation of BioScore: A biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma // Cancer, 2009; 115:2092-2103Search in Google Scholar

37. Sorb ellini M, Kattan MW, Snyder M, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma // J Urol, 2005; 173:48-51Search in Google Scholar

38. Sun M, Shariat SF, Cheng C, et al. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review// Eur Urol, 2011; 60(4):644-661Search in Google Scholar

39. Tan MH, Choong CV, Chia KS, et al. The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma // Cancer, 2011; 117:5314-5324Search in Google Scholar

40. Tang PA, Vickers MM, Heng DY, Heng YC. Clinical and molecular prognostic factors in renal cell carcinoma: what we know so far // Hematol Oncol Clin North Am, 2011; 25(4):871-891Search in Google Scholar

41. Tapp er H, Klein H, Rubenstein W, et al. Recurrent renal cell carcinoma after 45 years // Clin Imaging, 1997; 21(4):273-275Search in Google Scholar

42. Terr one C, Cracco F, Porpiglia F, et al. Reassessing the current TNM lymph node staging for renal cell carcinoma // Eur Urol, 2006; 49(2):324-31.Search in Google Scholar

43. Volpe A, Patard JJ. Prognostic factors in renal cell carcinoma // World J Urol, 2010; 28(3):319-327Search in Google Scholar

44. Wu Y, Fu X, Xiaoli Z, et al. Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis // J Cancer Res Clin Oncol, 2011; 137(5):887-896Search in Google Scholar

45. Zisman A, Pantuck AJ, Wieder J, et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma // J Clin Oncol, 2002; 20:4559-4566 Search in Google Scholar